Zhai Y - Search Results

1

Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions.

Wu H, Fu X, Zhai Y, Gao S, Yang X, Zhai G. Wu H, et al. Among authors: zhai y, zhai g. Adv Healthc Mater. 2021 Jul;10(13):e2100299. doi: 10.1002/adhm.202100299. Epub 2021 May 22. Adv Healthc Mater. 2021. PMID: 34021717 Review.

2

Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks.

Zhang Y, Rauf Khan A, Fu M, Zhai Y, Ji J, Bobrovskaya L, Zhai G. Zhang Y, et al. Among authors: zhai y, zhai g. J Drug Target. 2019 Nov;27(9):917-931. doi: 10.1080/1061186X.2019.1572158. Epub 2019 Feb 6. J Drug Target. 2019. PMID: 30672353 Review.

3

The progresses in curcuminoids-based metal complexes: especially in cancer therapy.

Zhang Y, Khan AR, Fu M, Zhai Y, Yu A, Zhai G. Zhang Y, et al. Among authors: zhai y, zhai g. Future Med Chem. 2019 May;11(9):1035-1056. doi: 10.4155/fmc-2018-0190. Epub 2019 May 29. Future Med Chem. 2019. PMID: 31140861 Review.

4

Pluronic F127-functionalized molybdenum oxide nanosheets with pH-dependent degradability for chemo-photothermal cancer therapy.

Chen Y, Khan AR, Yu D, Zhai Y, Ji J, Shi Y, Zhai G. Chen Y, et al. Among authors: zhai y, zhai g. J Colloid Interface Sci. 2019 Oct 1;553:567-580. doi: 10.1016/j.jcis.2019.06.066. Epub 2019 Jun 20. J Colloid Interface Sci. 2019. PMID: 31238227

5

Progress in tumour-targeted drug delivery based on cell-penetrating peptides.

Kong X, Xu J, Yang X, Zhai Y, Ji J, Zhai G. Kong X, et al. Among authors: zhai y, zhai g. J Drug Target. 2022 Jan;30(1):46-60. doi: 10.1080/1061186X.2021.1920026. Epub 2021 May 4. J Drug Target. 2022. PMID: 33944641

6

Research progress of tumor targeted drug delivery based on PD-1/PD-L1.

Liu D, Gao S, Zhai Y, Yang X, Zhai G. Liu D, et al. Among authors: zhai y, zhai g. Int J Pharm. 2022 Mar 25;616:121527. doi: 10.1016/j.ijpharm.2022.121527. Epub 2022 Jan 30. Int J Pharm. 2022. PMID: 35104594 Review.

7

Cellular drug delivery system for disease treatment.

Wang L, Zhang Y, Ma Y, Zhai Y, Ji J, Yang X, Zhai G. Wang L, et al. Among authors: zhai y, zhai g. Int J Pharm. 2023 Jun 25;641:123069. doi: 10.1016/j.ijpharm.2023.123069. Epub 2023 May 22. Int J Pharm. 2023. PMID: 37225024 Review.

8

Advances in tumor stroma-based targeted delivery.

Wu C, Zhai Y, Ji J, Yang X, Ye L, Lu G, Shi X, Zhai G. Wu C, et al. Among authors: zhai y, zhai g. Int J Pharm. 2024 Oct 25;664:124580. doi: 10.1016/j.ijpharm.2024.124580. Epub 2024 Aug 13. Int J Pharm. 2024. PMID: 39142464 Review.

9

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases.

Zhai Y, Moosavi R, Chen M. Zhai Y, et al. Front Immunol. 2021 Apr 21;12:645699. doi: 10.3389/fimmu.2021.645699. eCollection 2021. Front Immunol. 2021. PMID: 33968036 Free PMC article. Review.

10

Diphtheria toxin-derived, anti-PD-1 immunotoxin, a potent and practical tool to selectively deplete PD-1⁺ cells.

Zhang T, Dong S, Zhai Y, Naatz L, Zhou Z, Chen M. Zhang T, et al. Among authors: zhai y. Protein Sci. 2023 Sep;32(9):e4741. doi: 10.1002/pro.4741. Protein Sci. 2023. PMID: 37515422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,529 results

Search Page

Filters